- It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
BioMarin Pharmaceutical: "I'm getting tired of the orphan drug model...I don't think it works now."
Watch NBC 5 free wherever you are
WATCH HEREUnion Pacific: "I think it's a buy...I think it's a really good stock to own."
GitLab: "I was prepared for disappointment and I got it...I just do not want enterprise software. I think they're all too expensive."
Get top local stories delivered to you every morning with NBC DFW's News Headlines newsletter.
SIGN UP ARS Pharmaceuticals: "I like their model...It's a great flier. Someone needs that technology, someone's going to pay for it."
NuScale Power: "...If it does an offering here, that's when I'd buy. I'd wait for the stock offering after what happened with Oklo tonight."
Money Report
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Disclaimer
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com
